FBXO7 and Parkinson disease: Collectively, these data support a model whereby the loss of FBXO7 expression in dopaminergic neurons affects a number of pathways which lead to cell loss in the SNpc, and a locomotor defect – two hallmark features of Parkinson's disease – from 20 weeks of age.